Programa de Pós-Graduação em Assistência Farmacêutica - PPGAF/ICS
URI Permanente desta comunidadehttps://repositorio.ufpa.br/handle/2011/15126
Navegar
Navegando Programa de Pós-Graduação em Assistência Farmacêutica - PPGAF/ICS por Autor "http://lattes.cnpq.br/3848996822163999"
Agora exibindo 1 - 2 de 2
- Resultados por página
- Opções de Ordenação
Item Acesso aberto (Open Access) Acompanhamento farmacoterapêutico de pacientes pediátricos submetidos à sedoanalgesia em um hospital de alta complexidade em Belém-Pa(Universidade Federal do Pará, 2022-12-06) ELMESCANY, Sâmella Benoliel; RIBEIRO, Carolina Heitmann Mares Azevedo; http://lattes.cnpq.br/3848996822163999; https://orcid.org/0000-0002-9457-2733; FONTES JÚNIOR, Enéas de Andrade; http://lattes.cnpq.br/7056265073849866; https://orcid.org/0000-0002-6186-9581Introduction: The Intensive Care Unit (ICU) is a hospitalization unit for critically ill patients, whomostly use sedatives and analgesics. Seeking tominimize undesirable events, clinical follow-up of patients, especially pediatric patients, is necessary. Objective: To propose an instrument for pharmacotherapeutic monitoring of patients undergoing sedoanalgesia in the pediatric ICU. Method: Retrospective study, with data collected from medical records of patients aged 0 to 14 years, admitted to the pediatric ICU during the study period, who used sedoanalgesics. Results and discussion: In 326 prescriptions in the 90-day period involving 96 children, the age group of07-09 years predominated, with 49.2% underweight and predominantly male. Among the drugs prescribed were antimicrobials, sedoanalgesics, antipyretics and proton pump inhibitors. The average length of hospital stay was 18.5 days and approximately 32.7% of the patients had Withdrawal Syndrome (AS), corroborating the literature, where it is postulated that the longer thetime of use of these drugs, the greater the risk of SA. In 25% of the patients, 42.5% used antidotesother than those recommended by the Pediatrics and Pediatric & Neonatal Dosage Handbook. Asa product, a Manual for the Use of Sedoanalgesics was prepared to guide the multidisciplinary team in the care of patients during therapy. Conclusion: The data from this research indicated anunderweight public, the occurrence of medication errors and withdrawal syndrome, among otherfactors that reinforce the need for the elaboration of an institutionalized protocol for the administration of sedoanalgesics, aiming to guarantee patient safety, prevent the occurrence of adverse events related to its use and direct the multidisciplinary team on the care to be adopted.Item Acesso aberto (Open Access) Desenvolvimento de uma ficha de admissão para pacientes hospitalizados com COVID-19 em um hospital no estado do Pará(Universidade Federal do Pará, 2022-11-18) CASTRO, Eline Fernandes Ribeiro de; RIBEIRO, Carolina Heitmann Mares Azevedo; http://lattes.cnpq.br/3848996822163999; https://orcid.org/0000-0002-9457-2733; ALBÉRIO, Carlos Augusto Abreu; http://lattes.cnpq.br/2335187399740995; https://orcid.org/0000-0002-9364-3990Objective: Develop an admission form for patients hospitalized for COVID-19 in a private hospital in the state of Pará. The application of the admission form aims at a more assertive clinical decision-making and the reduction of negative outcomes. Methodology: This is a retrospective, cross-sectional and quantitative study, carried out by collecting data from adult patients hospitalized with a diagnosis of COVID-19 from March to June 2020 at the hospital under study. Data collection was divided between patient-related information such as personal data and clinical data such as signs/symptoms on admission, comorbidities and length of stay. Records of vital signs and results of laboratory tests and imaging were also collected. The data obtained were tabulated in Microsoft Excel and statistical analysis Odds ratio and Chi-square with a significance level of 5%. Results: A total of 212 hospitalized patients were evaluated, predominantly male and aged between 60 and 80 years. The presence of comorbidities was identified in 70.8% (n 150) of the patients and, in this case, the occurrence of negative outcomes was higher. After the univariate analysis, the variables that proved to be significant in relation to the negative outcomes were: male gender, age group ≥80 years, presence of some comorbidity, palliative care, hospitalization time >20 days. Conclusion: These results create the possibility of conducting prospective studies to improve care tools for patients with COVID-19, including the development of predictive scales for severe illness. Key Words: COVID-19; SARS-Cov-2; Comorbidities; Hospitalization.